Latest
Locals CARsgen Therapeutics Announces 2026 Interim Results
Business CARsgen TherapeuticsAugust 19, 2026 SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2026 Interim Results.Business HighlightsCash and cash equivalents were around RMB1,400...



